BELLEVUE ASSET MANAGEMENT, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,404
+5.2%
380.0%0.00%0.0%
Q2 2023$3,235
+2.9%
380.0%0.00%0.0%
Q1 2023$3,144
+18.5%
38
+11.8%
0.00%0.0%
Q4 2022$2,654
-11.5%
340.0%0.00%0.0%
Q3 2022$3,000
+50.0%
340.0%0.00%
+100.0%
Q2 2022$2,0000.0%340.0%0.00%0.0%
Q1 2022$2,0000.0%34
-19.0%
0.00%0.0%
Q4 2021$2,000
-33.3%
42
-6.7%
0.00%
-50.0%
Q3 2021$3,000
+200.0%
45
+114.3%
0.00%
+100.0%
Q2 2021$1,000
-66.7%
21
-8.7%
0.00%
-50.0%
Q1 2021$3,0000.0%23
-11.5%
0.00%0.0%
Q4 2020$3,000260.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders